The chapter reviews a neonatology trial's outcomes at 36 weeks and two years corrected age, showing significant results in bronchopulmonary dysplasia and intubation rates. Discussion on exclusive vs. early less invasive surfactant therapy and implications for safety and effectiveness in preterm babies is explored, along with challenges in measuring respiratory function post-NICU stay.

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode